Return to Issue Details
EPIDEMIOLOGICAL AND CLINICAL PROFILE OF NOTIFICATIONS RELATED TO ADVERSE EVENTS TO BOTULINUM TOXIN IN BRAZIL: AN ANALYSIS OF DATA FROM VIGIMED (2018–2025)
Download
Download PDF